Invest in 5,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California. more
Time Frame | ISRG | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.41% | 0.68% | 2.13% |
1-Month Return | -5.25% | -4.12% | -2.34% |
3-Month Return | -1.32% | 0.49% | 4.18% |
6-Month Return | 44.74% | 14.32% | 23.68% |
1-Year Return | 23.47% | 6.35% | 24.66% |
3-Year Return | 30.03% | 20.92% | 27.15% |
5-Year Return | 119.94% | 72.3% | 88.71% |
10-Year Return | 831.24% | 184.16% | 227.3% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 4.48B | 4.36B | 5.71B | 6.22B | 7.12B | [{"date":"2019-12-31","value":62.86,"profit":true},{"date":"2020-12-31","value":61.18,"profit":true},{"date":"2021-12-31","value":80.15,"profit":true},{"date":"2022-12-31","value":87.34,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.37B | 1.50B | 1.75B | 2.03B | 2.39B | [{"date":"2019-12-31","value":57.14,"profit":true},{"date":"2020-12-31","value":62.52,"profit":true},{"date":"2021-12-31","value":73.15,"profit":true},{"date":"2022-12-31","value":84.62,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 3.11B | 2.86B | 3.96B | 4.20B | 4.73B | [{"date":"2019-12-31","value":65.76,"profit":true},{"date":"2020-12-31","value":60.5,"profit":true},{"date":"2021-12-31","value":83.7,"profit":true},{"date":"2022-12-31","value":88.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 69.45% | 65.65% | 69.32% | 67.44% | 66.39% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":94.53,"profit":true},{"date":"2021-12-31","value":99.82,"profit":true},{"date":"2022-12-31","value":97.1,"profit":true},{"date":"2023-12-31","value":95.59,"profit":true}] |
Operating Expenses | 1.74B | 1.81B | 2.14B | 2.62B | 2.96B | [{"date":"2019-12-31","value":58.59,"profit":true},{"date":"2020-12-31","value":61.14,"profit":true},{"date":"2021-12-31","value":72.15,"profit":true},{"date":"2022-12-31","value":88.4,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 1.37B | 773.60M | 1.82B | 1.21B | 1.77B | [{"date":"2019-12-31","value":75.48,"profit":true},{"date":"2020-12-31","value":42.48,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":66.52,"profit":true},{"date":"2023-12-31","value":97.02,"profit":true}] |
Total Non-Operating Income/Expense | 255.40M | 590.60M | 138.60M | 425.20M | 384.20M | [{"date":"2019-12-31","value":43.24,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":23.47,"profit":true},{"date":"2022-12-31","value":71.99,"profit":true},{"date":"2023-12-31","value":65.05,"profit":true}] |
Pre-Tax Income | 1.50B | 1.21B | 1.89B | 1.61B | 1.96B | [{"date":"2019-12-31","value":76.69,"profit":true},{"date":"2020-12-31","value":61.62,"profit":true},{"date":"2021-12-31","value":96.5,"profit":true},{"date":"2022-12-31","value":82.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 120.40M | 140.20M | 162.20M | 262.40M | 141.60M | [{"date":"2019-12-31","value":45.88,"profit":true},{"date":"2020-12-31","value":53.43,"profit":true},{"date":"2021-12-31","value":61.81,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":53.96,"profit":true}] |
Income After Taxes | 1.38B | 1.07B | 1.73B | 1.34B | 1.82B | [{"date":"2019-12-31","value":76.04,"profit":true},{"date":"2020-12-31","value":58.7,"profit":true},{"date":"2021-12-31","value":95.09,"profit":true},{"date":"2022-12-31","value":73.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 1.38B | 1.07B | 1.73B | 1.34B | 1.82B | [{"date":"2019-12-31","value":76.04,"profit":true},{"date":"2020-12-31","value":58.7,"profit":true},{"date":"2021-12-31","value":95.09,"profit":true},{"date":"2022-12-31","value":73.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 1.38B | 1.06B | 1.70B | 1.32B | 1.80B | [{"date":"2019-12-31","value":76.71,"profit":true},{"date":"2020-12-31","value":58.99,"profit":true},{"date":"2021-12-31","value":94.81,"profit":true},{"date":"2022-12-31","value":73.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 4.25 | 3.38 | 4.97 | 4.69 | 5.71 | [{"date":"2019-12-31","value":74.43,"profit":true},{"date":"2020-12-31","value":59.19,"profit":true},{"date":"2021-12-31","value":87.04,"profit":true},{"date":"2022-12-31","value":82.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
ISRG | |
---|---|
Cash Ratio | 3.49 |
Current Ratio | 5.55 |
Quick Ratio | 4.61 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ISRG | |
---|---|
ROA (LTM) | 8.00% |
ROE (LTM) | 15.82% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ISRG | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.11 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.88 |
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. | 1.13 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ISRG | |
---|---|
Trailing PE | 67.53 |
Forward PE | 61.73 |
P/S (TTM) | 19.15 |
P/B | 10.25 |
Price/FCF | NM |
EV/R | 18.41 |
EV/Ebitda | 59.92 |
PEG | 1.29 |
Undoubtedly, investors seem to have a new appetite for next-level revenue growth. Generative AI, GLP-1 weight-loss drugs and other breakthrough innovations (I’m not sure if the metaverse qualifies right now) seek to expand in some pretty massive markets. Some medical technology (med tech) stocks are capable of impressive growth as they aim to improve the lives of those with specific issues. With many top medical tech and device firms trading at reasonable prices, investors may wish to give them a closer look as the tech market grows increasingly choppy. Let’s examine three med tech stocks that are slightly undervalued relative to their impressive product portfolios and innovative pipelines that may be able to drive solid share price appreciation over the coming years. Intuitive Surgical (ISRG) Source: Sundry Photography / Shutterstock.com Intuitive Surgical (NASDAQ: ISRG ) is a $132 billion med tech titan innovating on surgical robotics’s cutting edge. The company recently took a slight breather, falling almost 7% after briefly breaching all-time highs of over $400 per share.
Robotics has moved far before the realm of science fiction, revolutionizing industries from manufacturing to healthcare. The robotics market is booming, and investors can benefit from the enormous potential of robotics stocks. According to Market Research Future, the global robotics market should reach more than $286 billion by 2032, growing at 16.7% CAGR. A number of different AI technologies, including natural language processing, machine learning and edge computing will be primary growth drivers. As robotics continues to permeate various sectors, it’s essential to look deeper into the individual companies shaping this industry. Now, let’s discover the top robotics stocks to buy to make early investors filthy rich! Intuitive Surgical (ISRG) Source: Sundry Photography / Shutterstock.com Intuitive Surgical (NASDAQ: ISRG ) is a pioneer and dominant player in the surgical robotics field. The company’s flagship da Vinci surgical system has revolutionized minimally invasive surgery. Intuitive Surgical’s business model is highly successful and scalable.
The value of the “global medical device market” is expected to jump from over $500 billion last year to nearly $800 billion “by 2030.” According to the World Health Organization , “a medical device can be any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article.” Among the most exciting medical devices from an investment point of view are robotic surgical products, plastic surgery devices, glucose measuring products for diabetes patients and general health monitoring systems. All of these offerings can become huge bestsellers and generate huge profits for companies. Further, the firms that market them and other popular medical devices can become takeover targets. One recent example of the latter phenomenon occurred earlier this month when Johnson & Johnson (NYSE: JNJ ) agreed to buy Shockwave Medical (NASDAQ: SWAV ), a medical device company that I’ve touted in multiple past columns. Here are three other groundbreaking medtech stocks to watch in 2024.
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the first quarter of 2024, reporting higher revenues and adjusted profit. First-quarter net profit, excluding one-off items, increased […] The post ISRG Earnings: Intuitive Surgical reports higher Q1 revenue and profit first appeared on AlphaStreet .
Decoding Intuitive Surgical Inc (ISRG): A Strategic SWOT Insight
Intuitive Surgical (ISRG) Surpasses Q1 Earnings, Faces Supply Challenges
Robotics stocks have been making incredible strides, transforming industries as diverse as healthcare, manufacturing and human capital management. As robots become smarter and more capable, the demand for robotics solutions will continue to soar. While the future is always uncertain, the potential of the robotics industry is undeniable. From self-driving cars to advanced surgical systems, the world is rapidly embracing robotics innovation. Investors eyeing long-term growth opportunities continue to closely monitor these companies, recognizing their potential to deliver outsized returns over the next decade. Now, let’s unpack the top robotics stocks on pace to triple by 2030! Nvidia (NVDA) Source: Below the Sky / Shutterstock.com Nvidia (NASDAQ: NVDA ) is at the forefront of the robotics revolution. The company’s graphic processing units (GPUs) are the powerhouse behind many advanced AI and machine learning applications. Nvidia is heavily invested in developing software platforms and tools specifically for robotics applications.
Make the most of a modest investment by putting it into Intuitive Surgical, Bristol Myers Squibb, and Novo Nordisk.
Intuitive Surgical Inc (ISRG) share price today is $372.14
Yes, Indians can buy shares of Intuitive Surgical Inc (ISRG) on Vested. To buy Intuitive Surgical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ISRG stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Intuitive Surgical Inc (ISRG) via the Vested app. You can start investing in Intuitive Surgical Inc (ISRG) with a minimum investment of $1.
You can invest in shares of Intuitive Surgical Inc (ISRG) via Vested in three simple steps:
The 52-week high price of Intuitive Surgical Inc (ISRG) is $403.76. The 52-week low price of Intuitive Surgical Inc (ISRG) is $254.85.
The price-to-earnings (P/E) ratio of Intuitive Surgical Inc (ISRG) is 67.17
The price-to-book (P/B) ratio of Intuitive Surgical Inc (ISRG) is 10.25
The dividend yield of Intuitive Surgical Inc (ISRG) is 0.00%
The market capitalization of Intuitive Surgical Inc (ISRG) is $132.00B
The stock symbol (or ticker) of Intuitive Surgical Inc is ISRG